Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 August 2005

Effect of pyrimethamine in experimental rheumatoid arthritis.

Farshid Saadat, Salvatore Cuzzocrea, Rosanna Di Paola, Mohammad Pezeshki, Mohammad Khorramizadeh, Mohammad Sedaghat, Alireza Razavi, Abbas Mirshafiey

Med Sci Monit 2005; 11(8): BR293-299 :: ID: 201062

Abstract

Background: Recent evidence has shown that the antimalarials are usefuldrugs in the treatment of various rheumatic diseases. The present study was designed to test the therapeuticeffect of pyrimethamine (PYR) in collagen-induced arthritis (CIA). Material/Methods: CIA was inducedin Lewis rats. The intraperitoneal administration of PYR and methotrexate (MTX) were started on day 25post-immunization and continued until final assessment on day 35. During this period, clinical examinationwas performed intermittently. Anti-C II Ab and nitric oxide (NO) synthesis were measured. The paws andknees were then removed for histopathology and radiography assay. The biocompatibility of PYR and MTXwere assessed using a fibrosarcoma cell line. Results: Data showed that i.p. injection of pyrimethamineto arthritic rats induced a significant reduction in paw edema. This beneficial effect was associatedwith a significant decrease in anti-CII antibody response compared with untreated rats. Histopathologicalassessment showed reduced inflammatory cell infiltrate in the joints of treated rats, and tissue edemaand bone erosion in the paws were markedly reduced following PYR therapy. Moreover, our radiography resultsparalleled our histological findings. Cytotoxicity analysis of PYR showed greater tolerability comparedwith MTX. Treatment with PYR significantly diminished nitric oxide formation in treated rats comparedwith untreated controls. Conclusions: Our findings shed light on the therapeutic efficacy of pyrimethaminein experimental rheumatoid arthritis compared with a choice drug (methotrexate), which may recommendedit as a second-line drug in the treatment of rheumatoid arthritis.

Keywords: Arthritis, Experimental - radiography, Antibodies - immunology, Arthritis, Experimental - radiography, Arthritis, Rheumatoid - radiography, Cell Line, Cell Survival - drug effects, Matrix Metalloproteinase 2 - metabolism, Nitric Oxide - blood, Pyrimethamine - therapeutic use, Rats, Inbred Lew

Add Comment 0 Comments

Editorial

01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315

0:00

In Press

Review article  

Impact of Workplace Bullying on Nursing Care Quality: A Comprehensive Review

Med Sci Monit In Press; DOI: 10.12659/MSM.944815  

Clinical Research  

Anterior Plate-Supported Cannulated Screw Surgery for Ankle Arthrodesis: Clinical and Radiologic Results in...

Med Sci Monit In Press; DOI: 10.12659/MSM.944452  

Clinical Research  

Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipo...

Med Sci Monit In Press; DOI: 10.12659/MSM.944462  

Database Analysis  

Systemic Immune-Inflammation Index (SII) as a Predictor of Short-Term Mortality Risk in Sepsis-Associated A...

Med Sci Monit In Press; DOI: 10.12659/MSM.943414  

Most Viewed Current Articles

17 Jan 2024 : Review article   2,048,648

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,553,068

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   690,454

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial   50,367

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750